TCRyption Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

TCRyption General Information

Description

Developer of novel TCR-based T cell therapy designed to rapidly clone physiologically relevant TCRs. The company's platform is used to identify TCRs recognizing a diverse array of epitopes regardless of haplotype with unmatched sensitivity and speed, enabling companies to develop a pipeline of product candidates that can treat cancer types and patient populations that are underserved by current approaches.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • New York, NY
  • United States
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • New York, NY
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TCRyption Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 15-Oct-2021 Completed Pre-Clinical Trials
1. Seed Round 07-Oct-2020 Completed Pre-Clinical Trials
To view TCRyption’s complete valuation and funding history, request access »

TCRyption Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
TIO Bioventures Venture Capital Minority
To view TCRyption’s complete investors history, request access »

TCRyption FAQs

  • Where is TCRyption headquartered?

    TCRyption is headquartered in New York, NY.

  • What industry is TCRyption in?

    TCRyption’s primary industry is Biotechnology.

  • Is TCRyption a private or public company?

    TCRyption is a Private company.

  • What is TCRyption’s current revenue?

    The current revenue for TCRyption is .

  • How much funding has TCRyption raised over time?

    TCRyption has raised $10M.

  • Who are TCRyption’s investors?

    TIO Bioventures has invested in TCRyption.

  • When was TCRyption acquired?

    TCRyption was acquired on 15-Oct-2021.

  • Who acquired TCRyption?

    TCRyption was acquired by Treadwell Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process